Sparkassenkapital Ulm GmbH
Overview
Sparkassenkapital Ulm GmbH is the private equity investment arm of Sparkasse Ulm, which acquires, holds, manages, and sells equity in medium-sized companies, primarily within the business area of Ulm and the Alb-Donau district.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NVision | Jun 2023 | Series A | Co-investor |
| Hellstern Medical | Jan 2026 | Strategic | Co-investor |
| NVision | Jun 2023 | Series A | Co-investor |
| XITO | Mar 2023 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sparkassenkapital Ulm GmbH based?
Sparkassenkapital Ulm GmbH is headquartered in Ulm, Germany.
When was Sparkassenkapital Ulm GmbH founded?
Sparkassenkapital Ulm GmbH was founded in 2005.
How many portfolio companies does Sparkassenkapital Ulm GmbH have?
Sparkassenkapital Ulm GmbH has 7 portfolio companies in Caplight's dataset.
What are some companies in Sparkassenkapital Ulm GmbH's portfolio?
Portfolio companies visible on Caplight include NVision, Hellstern Medical, NVision, XITO.
What was Sparkassenkapital Ulm GmbH's most recent investment shown here?
Sparkassenkapital Ulm GmbH's most recent investment in this portfolio sample was in Hellstern Medical in 2026.
What sectors does Sparkassenkapital Ulm GmbH focus on?
Sparkassenkapital Ulm GmbH focuses on Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.
What company stages does Sparkassenkapital Ulm GmbH focus on?
Sparkassenkapital Ulm GmbH typically invests at the Early stage.